The Cigna Group (ETR:CGN)
Market Cap | 65.99B |
Revenue (ttm) | 223.11B |
Net Income (ttm) | 4.27B |
Shares Out | n/a |
EPS (ttm) | 15.53 |
PE Ratio | 15.44 |
Forward PE | 9.39 |
Dividend | 5.86 (2.35%) |
Ex-Dividend Date | Sep 4, 2025 |
Volume | 26 |
Average Volume | 18 |
Open | 249.40 |
Previous Close | 250.35 |
Day's Range | 249.40 - 250.85 |
52-Week Range | 247.50 - 261.10 |
Beta | 0.56 |
RSI | 33.83 |
Earnings Date | Oct 30, 2025 |
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company’s Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other product... [Read more]
Financial Performance
In 2024, The Cigna Group's revenue was $247.12 billion, an increase of 26.56% compared to the previous year's $195.27 billion. Earnings were $3.43 billion, a decrease of -33.50%.
Financial numbers in USD Financial StatementsNews
Zacks Industry Outlook Highlights Cigna and Humana
Cigna and Humana stand out in the HMO space, leveraging growth platforms and Medicare demand despite cost and regulatory pressures.
Validea Detailed Fundamental Analysis - CI
Below is Validea's guru fundamental report for CIGNA GROUP (CI). Of the 22 guru strategies we follow, CI rates highest using our Earnings Yield Investor model based on the published strategy of Joel G...
January 2028 Options Now Available For The Cigna Group (CI)
Investors in The Cigna Group (Symbol: CI) saw new options become available today, for the January 2028 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is ...

A Look Into Cigna Group Inc's Price Over Earnings
In the current market session, Cigna Group Inc. (NYSE: CI) share price is at $303.23, after a 0.86% drop. Over the past month, the stock increased by 2.15% , but over the past year, it actually fell ...
Cigna (CI) Reports Flat Employer Coverage for Obesity Drugs
Cigna (CI) Reports Flat Employer Coverage for Obesity Drugs

Cigna cites flat obesity drug coverage rates among employers
Cigna (CI) reports flat employer coverage rates for obesity drugs like Wegovy from Novo Nordisk (NVO) and Zepbound from Eli Lilly (LLY). Read more here.

Rate of employers covering weight-loss drugs is flat, Cigna says
Cigna said on Wednesday the percentage of employers paying for obesity drugs has remained flat year-over-year, though the health insurer still sees an uptick in demand for the wildly popular treatment...

The Cigna Group Announces Appearance at the Morgan Stanley 23rd Annual Global Healthcare Conference
BLOOMFIELD, Conn. , Sept. 10, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced that Brian Evanko, President and COO of The Cigna Group, and Ann Dennison, EVP and CFO of t...
Cigna (CI) Faces Challenges with 2026 Star Rating Changes
Cigna (CI) Faces Challenges with 2026 Star Rating Changes
Notable healthcare headlines for the week: Novartis, Cigna and Sanofi in focus
Get the latest S&P 500 healthcare sector updates, market movers, and key pharma deals.

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (Sept. 2025)
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (Sept. 2025)

AM Best Assigns Issue Credit Ratings and Indicative Issue Credit Ratings to The Cigna Group
AM Best has assigned a Long-Term Issue Credit Rating (Long-Term IRs) of “bbb+” (Good) to The Cigna Group’s (Cigna) (headquartered in Bloomfield, CT) [NYSE: CI] new senior unsecured notes. In addition,...

AM Best Assigns Issue Credit Ratings and Indicative Issue Credit Ratings to The Cigna Group
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned a Long-Term Issue Credit Rating (Long-Term IRs) of “bbb+” (Good) to The Cigna Group's (Cigna) (headquartered in Bloomfield, CT) [NYSE:...
Barclays Raises Price Target for Cigna (CI) to $383 | CI Stock News
Barclays Raises Price Target for Cigna (CI) to $383 | CI Stock News

Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers
Cigna Group’s (NYSE: CI) Evernorth Health Services announced on Tuesday a $3.5 billion investment in Shields Health Solutions , a specialty pharmacy management company. How is CI stock doing now? Che...

Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers
Cigna Group's CI Evernorth Health Services announced on Tuesday a $3.5 billion investment in Shields Health Solutions, a specialty pharmacy management company.
Cigna (CI) Invests $3.5 Billion in Shields Health Solutions
Cigna (CI) Invests $3.5 Billion in Shields Health Solutions
Adia Med Finalizing In-Network Access with the Nation's Largest Health Insurers Including ...
Adia Med Finalizing In-Network Access with the Nation's Largest Health Insurers Including Medicare, Medicaid, Humana, Cigna, and Florida Blue | ADIA Stock News
Cigna's Evernorth Health Services invests in Symacore's Shields Health

Adia Med Finalizing In-Network Access with the Nation's Largest Health Insurers Including Medicare, Medicaid, Humana, Cigna, and Florida Blue
Winter Park, Florida--(Newsfile Corp. - September 2, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a rising name in regenerative medicine, is thrilled to announce a transformative step toward expanding p...
Cigna files mixed securities shelf

Cigna's Evernorth invests $3.5 billion in Shields
Cigna Group's unit Evernorth Health on Tuesday said it is investing $3.5 billion in specialty pharmacy company Shields Health.

Evernorth Health Services Announces Investment in Shields Health Solutions
Investment Further Enhances Evernorth's Participation in Growing Market for Specialty Medicine BLOOMFIELD, Conn. , Sept. 2, 2025 /PRNewswire/ -- Evernorth Health Services ("Evernorth"), a subsidiary...
Mike Vinokur's Past Picks: CIGNA, Rogers Communication & Corebridge Financial
Mike Vinokur, Portfolio Manager & Senior Wealth Advisor at Propellus Wealth Partners, iA Private Wealth, discusses his past stock picks and how they're doing in the market today.

Cigna: Market Pessimism Creates Value Opportunity
Cigna's stock drop after Q2 2025 is overdone; shares now trade at a 15% discount to their 5-year average, creating a compelling entry point. Despite mixed Q2 results and lower profit growth forecasts,...